Influence of estrogen plus progestin on breast cancer and mammography in healthy postmenopausal women: the Women's Health Initiative Randomized Trial.

By R. Chlebowski, S. Hendrix, R. Langer, M. Stefanick, M. Gass, D. Lane, R. Rodabough, M. Gilligan, M. Cyr, C. Thomson and 3 more. Journal of the American Medical Association (JAMA), 2003

1,097 citations recorded by the source corpus.

Subfields: Cancer Research, Oncology

View Paper: https://www.semanticscholar.org/paper/f97c5d2bd93d3c45d64dd834a726686b838fccb4

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Cancer Research

A. Jemal

In Oncology

Citations in the corpus

Men: good health and high mortality. Sex differences in health and aging (2008, background): “The Women’s Health Initiative (WHI) trial revealed an excessive risk of CHD events, pulmonary embolism, stroke and breast cancer among post-menopausal women receiving estrogen plus progestin compared with a placebo group, although the protective effect of HRT for colorectal and endometrial cancers a”
Progesterone receptors: form and function in brain. (2008, neutral): “In addition to P4 action in the uterus, P4 can promote proliferation in the breast [151,215,26,50].”
Ductal carcinoma in situ of the breast: a systematic review of incidence, treatment, and outcomes. (2010, background): “The Women’s Health Initiative, a large randomized trial of HRT and breast cancer risk, found no increased risk of DCIS associated with HRT (13,14).”
Trends in Breast Cancer by Race and Ethnicity: Update 2006 (2006, result): “The increase among White women age 50 and older may also be related to HRT use,(27,28) which has been associated with increased risk of developing larger and more advanced breast tumors.(17) If use of HRT has contributed to the increase in regional stage disease among women over age 50, we should se”
European guidance for the diagnosis and management of osteoporosis in postmenopausal women (2008, background): “In a subsequent analysis, the increase in breast cancer risk was much less in women not previously exposed to HRT [234].”
The 2012 Hormone Therapy Position Statement of The North American Menopause Society (2012, neutral): “may impede the diagnostic interpretation of mammograms, therein delaying the diagnosis of breast cancer.(74,76) Evolving but not conclusive evidence suggests that the increased risk of breast cancer with EPT may be a result of the promotion of”
Risk of complications of pregnancy in women with type 1 diabetes: nationwide prospective study in the Netherlands (2004, background): “However, at these ages 5 years’ use of hormone therapy would lead to a greater increase in the absolute incidence of breast cancer and of stroke than any reduction in the absolute incidence of hip fracture.(1,3,21,22) No data were available for women older than 70 years.”